Clinical Trial Update: Study to Assess Efficacy and Safety of Aclidinium Bromide and Aclidinium Bromide/Formoterol Fumarate in Stabile COPD Patients [Phase 3]

View source ↗

Summary

Phase 3 trial in stable chronic obstructive pulmonary disease evaluating aclidinium bromide and the aclidinium bromide/formoterol fumarate combination has compl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Aclidinium bromide (Aclidinium bromide)
• Aclidinium bromide/formoterol fumarate (Aclidinium bromide/formoterol fumarate)

Snippet

Sponsor: AstraZeneca | Conditions: COPD | Phase 3 | Status: COMPLETED | Results posted: 2025-03-26